The Central drug regulator, DCGA has approved emergency use authorisation of the Russian Vaccine, Sputnik V. It has now become the third vaccine to get emergency use authorisation from the drug regulator after Covishield and Covaxin. The Vaccine was developed by Gamaleya National Research Institute of Epidemiology and Microbiology last year in Russia.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
About Sputnik V clinical trial:
Important takeaways for all competitive exams:
In a gesture of solidarity and recognition, Palestinian journalists covering the crisis in Gaza have…
Retired Justice Sanjaya Kumar Mishra has been appointed as the President of the Goods &…
Atanu Chakraborty's re-appointment as part-time Chairman of HDFC Bank for three years, effective from May…
American Express is set to inaugurate its expansive new campus in Gurugram, spanning nearly one…
In the latest edition of the World Press Freedom Index published annually by Reporters Without…
Shashi Bhushan Singh, a 2010-batch Indian Railway Traffic Service (IRTS) officer, has been appointed as…